Startup accelerator, investor, and ecosystem builder based in Trondheim, Norway! See more on LinkedIn: linkedin.com/company/6am-accelerator Accelerator: We host a 6-month accelerator program for pre-seed tech startups focused on business development, such as fundraising, sales, marketing, and legal. 35+ startups have attended since 2021. Investments: We facilitate a pre-seed investment fund called Gnist Capital, where we invest up to 1 MNOK. Ecosystem building: StartupTRD is a project aiming to increase the attractiveness of the Trondheim startup scene, including regular events, co-working, corporate innovation, and more. Check out startuptrd.no.

Oivi is preventing blindness among diabetes patients by deploying an AI camera for the automated diagnosis of retinal diseases. We are an ambitious and young medtech company developing a technology to overcome a huge challenge that impacts the lives of millions of people with diabetes. Our vision is to bring to market a low-cost artificial intelligence-enabled retinal camera and automated diagnostics platform for the early screening of Diabetic Retinopathy. We are an experienced team based in Norway and India, trying to achieve what nobody has done so far and we are trying to get there with high speed. Want to join us?

We believe that live esports should be available to everyone, in a way that makes it easy to follow and easy to understand. Our goal is to make it available anytime, anywhere, and to unify it all in one place. That’s why we’re building a platform that will revolutionize the way you consume live esports.

We have developed a camera-based sensor for 24h automatic sea lice counting and biomass measurement. Our product solves the main challenges in high contrast underwater imagery of sea lice with deficient maintenance. We are looking for funding to take the effect to the next level, where approval of our solution in the industry and by authorities are key factors as well as the development of the organization.

I started UVanTECH based on my experience in Automation and water treatment systems for the public, fish farming, offshore, and Ballast water treatment systems. There is now an international requirement that all ships, in commercial operation, must install Ballast water treatment systems. In UVanTECH we make UV powers that require 50% less space and reduce power consumption by 25% The product is patented and tested according to international marine standards. A contract is signed whit a major actor in the Ballast water market. The Business area is: - UV Powers for rough environments - Consultant and service for UV Systems, Filters, Flowmeters, Flow and Pressure Control valves. - Ballast water treatment systems for ships (BWT) - Fish Farms and Aquaculture - General Water treatment

OncoImmunity is a bioinformatics company providing unique machine-learning software to identify tumor-specific mutations that can be targeted by a patient’s own immune system (known as neoantigens). The OncoImmunity solution is important because recent breakthroughs in the field of Immuno-Oncology (I-O) such as the development of checkpoint inhibitors and personalized cancer vaccines, clearly demonstrate that a patient’s immune system can be harnessed to successfully treat cancer. The cost of identifying tumor-specific mutations in a patient’s cancer using next-generation sequencing (NGS) is now trivial and this technology will be key to enabling truly personalized immunotherapies to be developed in a technically and economically feasible manner. However, the remaining challenge that currently limits the field, and which is addressed by the OncoImmunity solution, is predicting which tumor-specific mutations can stimulate a patient’s immune system i.e. are immunogenic. Using NGS data as input, the OncoImmunity software enables accurate patient selection for cancer immunotherapy and can identify optimal targets for personalized cancer vaccines & cell therapies in a clinically actionable time frame. Beginning from this first product offering, OncoImmunity has the vision to become the world’s leading provider of software to guide cancer immunotherapy to improve survival rates for cancer patients. To achieve this OncoImmunity has assembled a growing team of world-class bioinformaticians, data scientists, and software engineers; developing its cutting-edge machine-learning technology that will help fulfill the promise of immunotherapy in the fight against cancer. OncoImmunity’s technology will disrupt the I-O field by offering regulatory-compliant prediction software on a software-as-a-service basis (SaaS). This will allow big pharma, biotechnology, and immunotherapy companies of any size to access OncoImmunity’s cutting-edge prediction software. The company is headquartered in an ideal scientific and entrepreneurial ecosystem to develop its technology at the Oslo Cancer Cluster Incubator; adjacent to the Institute for Cancer Research and the Norwegian Radium Hospital. OncoImmunity is a privately held company, founded in 2014 by experienced bioinformatics scientists (Dr. Trevor Clancy and Professor Eivind Hovig), and an experienced immunologist with a business development background (Dr. Richard Stratford). The company is backed by private financing from the Norwegian Radium Hospital Research Foundation, the Norwegian Cancer Society, STARTUPLAB, and Grotmol Solutions, in addition to a number of private software investors. The company is also supported by grants awarded from the Norwegian Research Council, Innovation Norway, and the EU. The company has already established both national and international collaborations and pilot projects to develop further proof-of-concept data and validate its software.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

AnsuR solves globally applicable challenges related to photo and video communication in mobile radio and satellite networks. Visual data constitutes over 70% of all Internet traffic, and as sensor resolution increases, the need for communication bandwidth increases correspondingly. The AnsuR software system RAIDO can reduce the bandwidth requirements by 99% via unique solutions to the fundamental challenges. Advanced Computer vision solutions with deep learning at being developed. RAIDO is also a Big Data communication solution, suitable for large sensor populations and the Internet of Things (IoT). RAIDO is certified for use in mobile satellite systems, where the challenges are particularly challenging, but everyone has also experienced bad mobile cell phone coverage. AnsuR makes critical information available to remote users. In drones and autonomous aerial vehicles and surface vessels, the ability to communicate camera content independently of the terrestrial infrastructure is key. RAIDO can also solve problems with large emails and documents due to images and graphics and provide Super-light Interactive Documents, showing the ability to transform how we communicate visual data. AnsuR has based its first years since the start of operations in 2006 on research and innovation, has currently sold the key products to representative customers for list price, and is ready to ramp up activities, marketing, and sales efforts. Both technology and market are proven. AnsuR has about 15 employees in hi-tech software engineering, located in Oslo and Barcelona. The company is currently self-funded and has not yet taken any investments. The shareholders are basically the founders and the employees.

ZEN OCEANS is a startup developing fully electric, autonomous-ready ships to affordably decarbonize ocean transport. We will think big and nudge the market for fully electric ships from 0 to 1. To fund our vision, we will develop products that in themselves can scale into large revenue-generating operations; among them maritime batteries (ZENERGY) and autonomy solutions (OCEANEYE). The future of ocean shipping is simple, safe, and sustainable - the frictionless fabric of global trade. Consequently, we consider the argument for electric and autonomous ships to be very strong. We envision a fleet of electric ships deployed at scale, coordinated by an intelligent network for the efficient movement of goods. The future starts now. Maritime batteries: We develop safe and low-cost maritime batteries for large energy systems. Type approval by DNV is ongoing. Fully electric ships: We develop energy- and cost-effective electric ship concepts for short sea trade and more. If you want to learn more, please reach out to us!

Startup Migrants is a company based in Berlin and Oslo. We help cities to boost job creation. We are passionate about collecting and analyzing data that can help cities to solve their challenges. Our data is collected from 15 countries, 45 cities and over 200 in depth interviews with policy makers, entrepreneurs, NGOs and migrant founders. We also have created Startup Preschool, a 3-day crash course in entrepreneurship with and for young multicultural talents. We have so far done 84 Preschools and planning to many more in Norway, Germany, Austria and the UK and other countries. Our more than 1000 participants are now part of an acive alumni group and go on applying to accelerators and starting companies.

In 2015 the UN implemented 17 Sustainable Development Goals, aiming for a sustainable society by 2030. Today we register the US withdrawing from the Paris agreement, CO2 levels at an all time high and increased polarization in our society. We, the youth, are fighting every day to rally the wider population. We are running short of time and change needs to happen now. Our leadership tool shall empower us to gather people around sustainability. Anyone can be a mini Greta with our (r)evolutionary technology.

Ever thought of growing food at home or in your office? We have developed a furniture for home growing, where the customer gets the conditions necessary to grow vegetables like lettuce and herbs indoor. The concept is based on hydroponic growing (e.g. the plants grow in water), and LED-lights. We are now taking this product to the market, and need someone to execute on the ideas.

We are pioneers in the field of 3D printed spare parts. Our core mission is to develop, produce and sell world leading and fully integrated  Additive Manufacturing (AM) solutions for deployed use.   We increase our customers' operability and readiness level, by providing fully self-sustained production labs on site. Our containers may be transported via land, sea or even air. We create innovative solutions to complex problems based on cutting edge AM technology and software solutions.

A fresh, fragrant and good-looking secondhand store. Can you imagine?   Label Secondhand will be the first secondhand trade store in Norway. We buy and sell clothing for both genders. Customers can sell their clothing in store. We put a sales price on items that meet our criteria, and give the customer 30% of that particular price in return.    By linking sustainability with the market demand for fashion, Label will help shrink the environmental footprint that the fast fashion industry leaves behind.

Leieting is Norway's largest peer-to-peer rental marketplace. Users across the whole country rent each others cars, motorcycles, camera equipment and hiking gear. All transactions are secured by the platform and insurance is provided with our partner If Insurance for up to 1 MNOK. The company has already raised EUR 380K with more than 50 investors from our usersbase.